Compare MCRB & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCRB | TAYD |
|---|---|---|
| Founded | 2010 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.7M | 132.1M |
| IPO Year | 2015 | N/A |
| Metric | MCRB | TAYD |
|---|---|---|
| Price | $17.19 | $48.21 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 323.3K | 4.6K |
| Earning Date | 11-05-2025 | 01-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.62 | ★ 2.72 |
| Revenue | $351,000.00 | ★ $44,593,219.00 |
| Revenue This Year | N/A | $10.81 |
| Revenue Next Year | N/A | $8.37 |
| P/E Ratio | $28.23 | ★ $18.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.53 | $29.50 |
| 52 Week High | $29.98 | $53.73 |
| Indicator | MCRB | TAYD |
|---|---|---|
| Relative Strength Index (RSI) | 49.93 | 53.85 |
| Support Level | $16.61 | $47.74 |
| Resistance Level | $18.86 | $50.56 |
| Average True Range (ATR) | 3.42 | 1.31 |
| MACD | -0.19 | 0.03 |
| Stochastic Oscillator | 11.70 | 68.16 |
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.